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and Electronic Engineering, Jiangsu Normal University, Xuzhou, ChinaABSTRACT MicroRNAs are key regulators of gene expression at the posttranscriptional level. In this study, we focus on miR-
605 and miR-34a, which are direct transcriptional targets of p53 and in turn enhance its tumor suppressor function by acting
upstream and downstream of it, respectively. miR-605 promotes p53 activation by repressing the expression of mdm2, while
miR-34a promotes p53-dependent apoptosis by suppressing the expression of antiapoptotic genes such as bcl-2. What roles
they play in the p53-mediated DNA damage response is less well understood. Here, we develop a four-module model of the
p53 network to investigate the effect of miR-605 and miR-34a on the cell-fate decision after ionizing radiation. Results of numer-
ical simulation indicate that the cell fate is closely associated with network dynamics. The concentration of p53 undergoes few
pulses in response to repairable DNA damage, or it first oscillates and then switches to high plateau levels after irreparable dam-
age. The amplitude of p53 pulses rises to various extents depending on miR-605 expression, and miR-605 accelerates the
switching behavior of p53 levels to induce apoptosis. In parallel, miR-34a promotes apoptosis by enhancing the accumulation
of free p53AIP1, a key proapoptotic protein. Thus, both miR-605 and miR-34a can mediate cellular outcomes and the timing of
apoptosis. Moreover, miR-605 and PTEN complement each other in elevating p53 levels to trigger apoptosis. Taken together,
miR-605 and miR-34a cooperate to endow the network with a fail-safe mechanism for apoptosis induction. This computational
study also enriches our understanding of the action modes of p53-targeted microRNAs.INTRODUCTIONMicroRNAs (miRNAs) are noncoding RNAs 20–24 nucleo-
tides long. They posttranscriptionally repress the expression
of target genes by pairing to the 30 untranslated region of
messenger RNA (mRNA) and recruiting the RNA-induced
silencing complex, which mediates the repression of trans-
lation and the degradation of the target mRNA (1). More
than 30% of human protein-coding genes are regulated by
miRNAs (2). miRNAs can confer robustness to biological
processes by acting as buffers against random fluctuation
in gene expression (3).
The tumor suppressor p53 is a central player in the
cellular response to various stresses including DNA dam-
age, hypoxia, and oncogene activation (4). Once activated,
p53 selectively modulates expression of target genes
involved in cell cycle arrest, DNA repair, and apoptosis
(5). Besides protein-coding genes, p53 mediates the
expression of miRNAs, including the miR-34 family as
well as miR-192, miR-194, miR-215, miR-107, and miR-
605 (6–9). p53 is also involved in the processing of
miRNAs such as miR-16, miR-143, and miR-145 (10). It
has been shown that miRNAs are important components
of the p53 network and there exist intricate connections be-
tween p53 and its target miRNAs (11). How p53-targeted
miRNAs contribute to its tumor suppressor function is still
less well understood.Submitted September 20, 2013, and accepted for publication February 26,
2014.
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0006-3495/14/04/1792/9 $2.00Recently, it was shown experimentally that p53 dynamics
control cell fate (12). A series of computational studies have
also explored the dynamics and functions of p53 in response
to DNA damage. We proposed in previous articles that the
cell-fate decision between survival and death after ionizing
radiation (IR) can be determined by the number of p53
pulses (13,14) and that high plateau levels of p53 facilitate
apoptosis induction (14). Choi et al. reported that different
dynamic modes of p53, such as pulsing and sustained accu-
mulation, are associated with distinct cell fates (15). How-
ever, the effect of p53-targeted miRNAs on cellular output
is largely neglected in the modeling of p53 signaling. It is
important to investigate what roles miRNAs may play in
the p53-mediated DNA damage response (DDR). Mean-
while, it is necessary to justify the previously proposed
mechanism for cell-fate decision in a wider context that in-
cludes the protein-miRNA interactions.
There are two kinds of p53-targeted miRNAs worth
noting. The first can regulate p53 activity through repression
of its negative regulators such as Mdm2 and wild-type
p53-induced phosphatase 1 (Wip1) (9,16,17). For example,
miR-605 represses Mdm2 posttranscriptionally (9). Thus,
miR-605 can upregulate p53 via the p53-miR-605-Mdm2
positive feedback loop. The second kind of miRNA,
including miR-34a, can function downstream of p53 to
mediate cellular outcomes (18,19). The target proteins of
miR-34a include Bcl-2, SIRT1, E2F3, CDK4/6, and Myc
(20), and thus miR-34a promotes cell cycle arrest and
apoptosis. For simplicity, we can choose miR-605 and
miR-34a as representatives of these two kinds of miRNAhttp://dx.doi.org/10.1016/j.bpj.2014.02.032
miR-605 and miR-34a Promote Apoptosis 1793and probe how they cooperate to affect the DDR in a p53-
dependent manner.
Motivated by the above considerations, here we develop a
four-module network model of the p53 signaling pathway to
explore the influence of miR-605 and miR-34a on p53 dy-
namics and cell-fate decision after IR. Consistent with our
previous report (14), p53 undergoes one- or two-phase dy-
namics depending on the extent of DNA damage. miR-605
can accelerate the full activation of p53 to induce apoptosis,
while miR-34a promotes the accumulation of free p53-regu-
lated apoptosis-inducing protein 1 (p53AIP1), facilitating
apoptosis induction. Therefore, the involvement of miR-
605 and miR-34a ensures that severely damaged cells can
be removed promptly. This work suggests that p53-targeted
miRNAs play a critical role in p53 signaling; their effect on
gene expression could be amplified via positive feedback
and cascade response to elicit a large physiological effect.MATERIALS AND METHODS
Model
p53 is at the center of cellular signaling pathways responding to various
stresses (4). It is increasingly evident that miRNAs are important compo-nents of the p53 network (11,21). Here, we propose a four-module model
for the p53 network in response to IR, focusing on the impact of miRNAs
on the DDR. The model characterizes DNA repair, ataxia-telangiectasia
mutated (ATM) activation, regulation of p53 activity, and determination
of cellular outcome (Fig. 1). p53-centered feedback loops play key roles
in shaping p53 dynamics and modulating p53 activity (22). We con-
sider the p53-miR-605-Mdm2 and p53-PTEN (phosphatase and tensin
homolog)-Akt-Mdm2 positive feedback loops, as well as the p53-Mdm2
and ATM-p53-Wip1 negative feedback loops. The key points of the model
are presented as follows.Induction, repair, and detection of DNA damage
Upon IR, double-strand breaks (DSBs) are induced, and DNA repair pro-
teins are quickly recruited to break sites (23). For a population of cells
exposed to the same irradiation dose, DIR, the number of DSBs is assumed
to obey a Poisson distribution with a mean of 35 DIR (24). The total num-
ber of repair proteins is assumed to be 20/cell. We use the same method as
Zhang et al. (14) to simulate the DSB repair process. Each DSB site may be
in one of three states: intact, in complex with repair protein, and fixed, with
the total number of sites in each state denoted by ND, NC, and NF, respec-
tively. Both fast and slow repair processes are taken into account. The
two-lesion kinetic model is used to characterize the repair process (25).
As a detector of DSBs, the ATM kinase is activated via intermolecular
autophosphorylation (26). ATM exists predominantly as dimers in un-
stressed cells. After IR, DSBs promote conversion of ATM from
dimers to inactive monomers and to active, phosphorylated monomers.FIGURE 1 Schematic depiction of the model.
DSBs are induced upon IR, and the ATM kinase
is activated via autophosphorylation. Activated
p53 induces the expression of mdm2, miR-605,
and miR-34a. miR-605 and miR-34a repress the
translation of mdm2 and bcl-2 mRNAs, respec-
tively. Active p53 is further divided into p53-
arrester and p53-killer, which promote cell cycle
arrest and apoptosis, respectively. Dashed arrows
denote the expression of target genes by p53,
whereas solid arrows represent the transitions be-
tween proteins. Circle- and bar-headed lines
denote the promotion and inhibition, respectively,
of transition or production.
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1794 Zhou et al.Phosphorylated ATM (ATMp) further accelerates the activation of ATM
through intermolecular autophosphorylation. Consequently, ATMp be-
comes dominant and transmits the stress signal downstream by phosphory-
lating its substrates.0
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Activated ATM phosphorylates p53 and Mdm2, blocking the p53-Mdm2
interaction and promoting the rapid degradation of Mdm2 (27,28). As a
result, p53 is stabilized and activated. Only nuclear p53 is considered
here. Based on its phosphorylation status, p53 is divided into three forms:
unphosphorylated (p53, the inactive form), phosphorylated on Ser-15
(p53-arrester, the primarily activated form), and doubly phosphorylated
on Ser-15 and Ser-46 (p53-killer, the fully activated form) (13,14). Phos-
phorylated p53 is collectively symbolized by p53p. p53-arrester and p53-
killer induce cell-cycle arrest and apoptosis, respectively (29,30). Three
forms of Mdm2 are considered: the dephosphorylated cytoplasmic form
(Mdm2c), the phosphorylated cytoplasmic form (Mdm2cp), and the nuclear
form (Mdm2n). The mdm2 mRNA, mdm2m, is also included in the model.
We assume that only phosphorylated Mdm2 can enter the nucleus (31).
p53-arrester transactivates p21, Wip1, and p53DINP1 (p53-dependent
damage-inducible nuclear protein 1), whereas p53-killer transactivates
PTEN, p53AIP1, and p53DINP1 (29,30,32). p21 induces cell-cycle arrest,
whereas p53AIP1 promotes apoptosis. We assume that the rate constant
of p53DINP1 induction by p53-killer is much greater than that by p53-
arrester, because p53-killer has a higher affinity for the promoter of
p53DINP1 than does p53-arrester (30). The conversion between p53-
arrester and p53-killer is controlled by p53DINP1 and Wip1 (30,33).
p53DINP1 promotes the accumulation of p53-killer via phosphorylation
(30), whereas Wip1 promotes the reversion from p53-killer to p53-arrester
via dephosphorylation (33).
Wip1 also promotes the dephosphorylation of ATMp (34), and the ATM-
p53-Wip1 negative feedback loop is essential for uniform p53 pulses in the
DDR (35). PTEN promotes the conversion from phosphatidylinositol 3,4,5-
trisphosphate (PIP3) to phosphatidylinositol 4,5-trisphosphate (PIP2) via
dephosphorylation (36); PIP3 recruits Akt to the plasma membrane, pro-
moting its phosphorylation (37). Phosphorylated Akt (Aktp) phosphorylates
cytoplasmic Mdm2 to trigger its nuclear entry (31). Thus, there exists a
positive feedback loop comprising p53-killer, PTEN, PIP2/3, Akt, and
Mdm2 (38).
Active p53 induces the expression of miR-605 and miR-34a. miR-605
suppresses the translation of mdm2 mRNA (9). Thus, p53, miR-605, and
Mdm2 constitute a positive feedback loop. miR-34a can promote cell-cycle
arrest and apoptosis (20). Here, we focus on its proapoptotic function.
miR-34a represses Bcl-2 posttranscriptionally. As an antiapoptotic factor,
Bcl-2 inhibits p53AIP1 by forming a complex (39). Only free p53AIP1 in-
duces the release of cytochrome c (CytoC) from mitochondria into cyto-
plasm. Released CytoC results in the activation of caspase-3 (Casp3)
(40), and activated Casp3 further promotes CytoC release by cleaving its
inhibitors (41). Consequently, apoptosis ensues. For simplicity, we do not
explicitly consider the intermediate steps between CytoC release and
Casp3 activation, including the formation of apoptosomes and activation
of caspase-9 (42).0 1500 3000
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FIGURE 2 Dynamics of the p53 network. Time courses of (top to
bottom) NC, [ATMp], [p53p], [p21], and [Casp3] at DIR ¼ 2 Gy (A) or
6 Gy (B).Methods
The details of model construction are presented in the Supporting Material.
A Monte Carlo method (13,14,24) is used to mimic the DNA repair process.
The concentration of each species is represented by a state variable in rate
equations, which are presented in Supporting Material. Michaelis-Menten
kinetics is used to characterize the reactions involving phosphorylation
and dephosphorylation. All transcription of genes by p53 is characterized
by the Hill function, and the Hill coefficient is set to 4 given the coopera-
tivity of the tetrameric form of p53 as a transcription factor (43). TheBiophysical Journal 106(8) 1792–1800description of variables and their initial values are listed in Table S1. A
set of standard parameter values is listed in Table S2. The unit of time is
minutes, and irradiation dose is in units of Gray (Gy). The units of param-
eters are determined such that the concentration of proteins is dimension-
less. For simplicity, we did not indicate the units of the parameters
explicitly. Numerical integration of differential equations was performed
using a fourth-order Runge-Kutta algorithm with a time step of 0.01 min.
The bifurcation diagrams were plotted using Oscill8.RESULTS
Typical dynamics of the p53 network
We first exhibit the dynamics of key proteins under two
typical stress conditions. Upon IR, the number of DSB-pro-
tein complexes, NC, rises quickly to its maximum of 20 and
remains there until the number of DSBs drops below 20;
after that, NC falls gradually (Fig. 2). ATM is activated by
the presence of DSBs, and p53 is then activated by ATM;
the concentrations of ATMp and p53p first undergo pulses.
p53p induces p21 to arrest the cell cycle, allowing for
DNA repair. At DIR ¼ 2 Gy, since the damage is effectively
fixed after two p53 pulses, Casp3 remains inactive and the
cell recovers to normal proliferation (Fig. 2 A).
AtDIR¼ 6 Gy, NC is around the maximum for a long time
(Fig. 2 B). [ATMp] and [p53p] exhibit two-phase dynamics;
they first undergo three pulses and then switch to high
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FIGURE 3 Network dynamics in the two cases with ksmir605 ¼ 0 (black
curves) or 0.02 (gray curves). (A) Bifurcation diagram of [ATMp] versus
kswip1. NC is kept at 20. The solid and dashed lines represent stable and
unstable steady states, respectively. The dots represent the maximum and
minimum of oscillations. (B–F) Time courses of the levels of miR-605
(B), p53p (C and D), p53DINP1 (E), and Casp3 (F) at DIR ¼ 6 Gy. The
time course in D is a magnification of the second peak in C.
miR-605 and miR-34a Promote Apoptosis 1795plateau levels. Accordingly, p53-arrester and p53-killer are
the predominant forms of p53p in the first and second
phases, respectively (Fig. S1). That is, p53 is first primarily
activated and then fully activated. p21 is induced in the first
phase, whereas Casp3 is activated in the second phase. Here,
the irreversible activation of Casp3 is taken as a marker of
apoptosis induction, and the downstream apoptotic events
are not represented in the model. Thus, [p53p] still returns
to basal levels after the damage is fixed. In fact, the repair
proteins will be cleaved by Casp3, and the repair process
will stop after Casp3 activation. Consequently, apoptosis
is triggered before the DNA damage can be fully fixed in
severely damaged cells. Taken together, the cell fate is
closely associated with the network dynamics.
The two-phase behavior can be interpreted as follows. In
the first phase, Wip1 is induced by p53-arrester (Fig. S1),
and the ATM-p53-Wip1 negative feedback loop is essential
for generating ATM and p53 pulses (14,35). In the second
phase, Wip1 is expressed at low levels, and thus its repres-
sion of ATMp is released, elevating both [ATMp] and
[p53p]. Moreover, PTEN is induced by p53-killer, and
the p53-PTEN-Akt-Mdm2 positive feedback is markedly
strengthened, leading to the sequestration of Mdm2 in the
cytoplasm. Thus, [p53p] is driven to high levels. The above
results are consistent with our previous report (14): the
determination of cell fate is mediated by pulsing of p53
levels, and high levels of p53p facilitate apoptosis induction.
Compared with the case with a deficiency in both miR-605
and miR-34a, however, here the percentage of apoptotic
cells within a population can rise remarkably, and the
average time required for Casp3 activation drops markedly
at moderate doses, as shown later.Influence of miR-605 on p53 activity
It was reported in our previous work that a sufficient amount
of Wip1 is required for ATM and p53 oscillations (14). This
conclusion holds true even when the p53-miR-605-Mdm2
positive feedback loop is included in the model. Fig. 3 A
shows the bifurcation diagram of [ATMp] as a function of
the p53-inducible synthesis rate of Wip1, kswip1. Only
when kswip1 > 0.052 can [ATMp] undergo oscillations;
otherwise, [ATMp] shows bistability or monostability. There
exists a minor difference in the upper and lower thresholds
of kswip1 for bistability between the cases with ksmiR605 ¼ 0
and ksmiR605 ¼ 0.02 (the default value). In the following, we
describe the difference in network dynamics between the
two cases.
At DIR ¼ 6 Gy, [miR-605] also undergoes two phases in
the case of ksmiR605 ¼ 0.02, because it is directly induced by
p53p, in contrast to a lower constant level in the case of
ksmiR605 ¼ 0 (Fig. 3 B). The amplitude of p53p oscillation
only changes slightly between the two cases (Fig. 3, C
and D) (the difference will be enlarged with further increase
of ksmiR605). However, a small change may be amplified viapositive feedback, cascade responses, or temporal accumu-
lation to elicit a large physiological effect. Indeed, the
full activation of p53 and apoptosis are accelerated with
ksmiR605 ¼ 0.02, as explained below.
As mentioned above, p53-induced p53DINP1 promotes
the accumulation of p53-killer. Its concentration also oscil-
lates in the early phase, but the amplitude rises gradually
(Fig. 3 E). When [p53DINP1] reaches some threshold level,
p53-killer begins to predominate over p53-arrester. The dif-
ference in [p53DINP1] between the two cases increases over
time, and the threshold is reached first with ksmiR605 ¼ 0.02.
Thus, the number of p53 pulses decreases by one, and Casp3
is activated 325 min earlier with ksmiR605 ¼ 0.02 than with
ksmiR605 ¼ 0 (Fig. 3 F). Furthermore, it is shown in
Fig. S2 that the histogram of the time required for Casp3
activation is centered at 1370 min with ksmiR605 ¼ 0.02,
whereas it is centered around 1700 min with ksmiR605 ¼ 0.
Taken together, miR-605 promotes the accumulation of
fully activated p53 and facilitates p53-induced apoptosis.
The effect of miR-605 on p53 dynamics could be tested
experimentally by comparing the timing of p53 phosphory-
lation on Ser-46 in different situations. At high doses, over-
expression of miR-605 would advance the accumulation of
p53-killer, whereas knockdown of miR-605 would do the
opposite.
Indeed, miR-605 functions by repressing the translation
of mdm2 mRNA to modulate p53 dynamics (9). At DIR ¼
2 Gy, most of Mdm2 molecules enter the nucleus, andBiophysical Journal 106(8) 1792–1800
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1796 Zhou et al.thus [Mdm2n] is much greater than [Mdm2c] (Fig. 4, A
and B). Both [Mdm2n] and [Mdm2c] are less at ksmiR605 ¼
0.02 than at ksmiR605 ¼ 0. This difference is more remark-
able during the second phase at DIR ¼ 6 Gy, especially for
[Mdm2c] (Fig. 4, C and D). The maximum of [Mdm2c] in
the case of ksmiR605 ¼ 0.02 is nearly half that in the case
of ksmiR605 ¼ 0. This enhanced inhibition of [Mdm2c] by
miR-605 results from a marked increase in [miR-605] in
the second phase. Thus, the downregulation of Mdm2 can
be amplified by the p53-miR-605-Mdm2 loop. Of note,
the remarkable reduction in [Mdm2c] does not lead to a
marked increase in [p53p], since only a small amount of
Mdm2 enters the nucleus due to PTEN induction.FIGURE 5 Effect of miR-605 on p53 activity and cellular outcome in the
case of PTEN deficiency (with ksPTEN ¼ 0). (A) Bifurcation diagram of
[p53p] versus ksmiR605 at fixed NC ¼ 20. (B) Time courses of [p53-killer]
at DIR ¼ 6 Gy with ksmiR605 ¼ 0.02 (black), 0.07 (gray), or 0.15 (dotted).
(C) Mean time required to activate Casp3 at DIR ¼ 6 Gy as a function of
ksmiR605. (D) Percentage of apoptosis among a population of 2000 cells
versus DIR with ksmiR605 ¼ 0.02 (black), 0.07 (gray), or 0.15 (dotted).Effects of miR-605 and PTEN on apoptosis
induction
It has been reported that the expression of PTEN is impor-
tant for high levels of p53 and apoptosis induction after
severe DNA damage (14). At ksmiR605 ¼ 0.02, miR-605
shows no effect on the upregulation of p53 in the second
phase, given PTEN induction (cf. Fig. 3 C). However,
PTEN is often deficient in some cells, for example, because
of its promoter methylation (44). This raises the issue of
how [p53p] would reach high levels to trigger apoptosis in
that situation. We found that miR-605 may play a key role
in promoting apoptosis, compensating for PTEN deficiency.
Since [p53p], or [p53-killer] in the second phase, is close
to the steady-state level of p53p at fixed NC ¼ 20 (ignoring
DNA repair), we use the steady-state analysis to get an over-
all picture of how the expression of miR-605 affects [p53p]
in the second phase. With PTEN deficiency (ksPTEN ¼ 0),
the steady-state level of p53p rises monotonically with
increasing ksmiR605 (Fig. 5 A). That is, enhancing the expres-
sion of miR-605 elevates p53p levels. Fig. 5 B further shows
the temporal evolution of [p53-killer] at DIR ¼ 6 Gy. After0 1500 3000
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FIGURE 4 Effect of miR-605 on mdm2 expression. Time courses of the
levels of Mdm2c and Mdm2n at DIR ¼ 2 Gy (A and B) or 6 Gy (C and D).
The gray and black curves correspond to ksmiR605 ¼ 0.02 and 0, respec-
tively.
Biophysical Journal 106(8) 1792–1800the initial few pulses with very low amplitudes, [p53-killer]
can rise quickly to saturation. The time of onset, changing
rate, and plateau level of [p53-killer] all vary gradually
with ksmiR605. With ksmiR605 ¼ 0.02, [p53-killer] is not
high enough, and thus Casp3 remains inactive. When
ksmiR605 > 0.06, Casp3 can be activated in a switchlike
manner.
In a population of cells exposed to the same irradiation,
different numbers of DSBs can be induced in each cell,
obeying a Poisson distribution, and thus there may exist
distinct cellular outcomes. As seen in Fig. 5 C, the mean
time required to activate Casp3 drops with increasing
ksmiR605. Fig. 5 D shows the percentage of apoptotic cells
as function of the radiation dose, DIR, for different values
of ksmiR605. The percentage rises gradually toward 100%
with increasing DIR at fixed ksmiR605 (>0.06); it also rises
with increasing ksmiR605 if DIR < 4.5 Gy. That is, enhancing
the expression of miR-605 contributes to p53-dependent
apoptosis in PTEN-deficient cells. Thus, upregulation of
p53 to induce apoptosis occurs by two mechanisms, repres-
sing the expression of mdm2 by miR-605 and sequestering
Mdm2 in the cytoplasm through PTEN.
It is worth noting that the network dynamics is influenced
differently by PTEN than by miR-605. With ksmiR605 ¼
0.02, the steady-state level of p53p can exhibit bistability
over a range of ksPTEN (0.13–0.26) (Fig. 6 A). Beyond that
region, [p53p] settles at a moderate or high level. With
ksPTEN ¼ 0, p53-killer predominates over p53-arrester after
three pulses at DIR ¼ 6 Gy (Fig. 6 B), but its level is not
high enough, and Casp3 remains inactive (Fig. 6 C). With
ksPTEN¼ 0.14 or 0.5 (the default value), [p53-killer] is main-
tained at relatively high levels in the second phase, and thus
Casp3 is activated to induce apoptosis. Interestingly, the
timing of Casp3 activation changes slightly with ksPTEN.
A B
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FIGURE 6 Effect of PTEN on p53 activity and cellular outcome. (A)
Bifurcation diagram of [p53p] versus ksPTEN at fixed NC ¼ 20. The stable
and unstable steady states are denoted by solid and dashed lines, respec-
tively. (B and C) Time courses of [p53-killer] (B) and [Casp3] (C) at
DIR ¼ 6 Gy with ksPTEN¼ 0 (black), 0.14 (gray), or 0.5 (dotted). ksmiR605¼
0.02 in A–C. (D) To explore how the bifurcation points in Fig. 6 A change
with varying ksmiR605, Fig. 6 D shows the dependence of the upper and
lower thresholds of ksPTEN on ksmiR605.
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FIGURE 7 Effect of miR-34a on Bcl-2 activity and cellular outcome
at DIR ¼ 6 Gy. Time courses of [miR-34a] (A), [Bcl-2tot] (B), and
[p53AIP1] (C). The gray and black curves correspond to the cases with
ksmiR34a ¼ 0.02 and 0, respectively. (D) Mean time required to activate
Casp3, averaged over 2000 cells, versus ksmiR34a.
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amount of PTEN is required to induce apoptosis in severely
damaged cells; otherwise, enough miR-605 is required. In
fact, the two can complement each other in apoptosis induc-
tion (see below).
The two-parameter bifurcation diagram of ksmiR605 versus
ksPTEN characterizes the dependence of the upper and
lower thresholds of ksPTEN on ksmiR605 (Fig. 6 D). The lower
threshold of ksPTEN nearly remains fixed, whereas the
upper threshold drops with increasing ksmiR605. To ensure
apoptosis induction after severe DNA damage, the values
of ksPTEN and ksmiR605 should be taken from the top right re-
gion beyond that enclosed by two threshold lines. It should
be noted that sufficient expression of miR-605 or PTEN is
required when the other is deficient. miR-605 and PTEN
are separately involved in p53-centered positive feedback
loops, elevating p53p levels by downregulating nuclear
Mdm2. However, PTEN is induced in the later phase of
the cellular response to severe damage, whereas miR-605
has a role during the whole cellular response. Distinguishing
the difference between miR-605 and PTEN may be impor-
tant for designing efficient cancer therapies.Effect of miR-34a on apoptosis induction
In our model, miR-34a represses the translation of bcl-2
mRNA, increasing the amount of free p53AIP1. We first
compare the network dynamics when the p53-inducible syn-
thesis rate of miR-34a, ksmiR34a, is 0 or 0.02. With ksmiR34a¼
0.02, the level of miR-34a also undergoes two-phase dy-
namics at DIR ¼ 6 Gy, since it is directly induced by p53p
(Fig. 7 A). [miR-34a] reaches a relatively high level in the
second phase, promoting apoptosis induction. [Bcl-2tot] isreversely correlated with [miR-34a] (Fig. 7 B; see also
Fig. S3); [Bcl-2tot] drops markedly to an intermediate level
in the second phase, and the concentration of free p53AIP1
is maintained at a relatively high level (Fig. 7 C). In contrast,
with ksmiR34a ¼ 0, [miR-34a] remains at a rather low level,
whereas [Bcl-2tot] is kept at a high level; accordingly,
[p53AIP1] settles at an intermediate level. Note that the
mean time required to activate Casp3 rises remarkably
with decreasing ksmiR34a (Fig. 7 D). When ksmiR34a drops
from 0.02 to 0, for example, Casp3 activation is delayed
by ~1165 min. This marked delay results from the extended
integration of [Casp3] to reach its threshold level for activa-
tion (Fig. S3). Therefore, enhancing the expression of miR-
34a contributes to timely removal of irreparably damaged
cells. Compared with miR-605, miR-34a is more directly
involved in apoptosis induction.
It is interesting to compare the timing of Casp3 activation
at DIR ¼ 6 Gy under four conditions (Fig. 8 A). The curves
from left to right correspond to the cases with normal expres-
sion of both miR-34 and miR-605, miR-34a alone, miR-605
alone, and with a deficiency in both miR-605 and miR-34a,
respectively. Remarkably, apoptosis is accelerated to an
extent that depends on the expression ofmiRNAs. The curves
of the percentage of apoptotic cells versusDIR (Fig. 8B) shift
to the right in the same order as in Fig. 8 A. With the default
parameter setting, more apoptosis can be induced with
ksmiR34a ¼ 0.02 and ksmiR605 ¼ 0 than with ksmiR605 ¼ 0.02
and ksmiR34a¼ 0 for 3< DIR< 8 Gy. We note that our simu-
lation results agree with the quantified experimental data
from Fig. 5 of Xiao et al. (9) (Fig. 8 C, left and right,
respectively).
To explain these differences, we show the temporal evo-
lution of [p53p] and [Casp3] at DIR ¼ 5 Gy under various
conditions (Fig. S4). Only when [p53DINP1] reaches
some threshold does p53-killer become dominant overBiophysical Journal 106(8) 1792–1800
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FIGURE 8 Effect of miR-34a and miR-605 on apoptosis induction.
(A) Time courses of [Casp3] at DIR ¼ 6 Gy. (B) Percentage of apoptotic
cells within a population of 2000 cells versus DIR. Four cases are compared
with ksmiR605¼ 0.02 and ksmiR34a¼ 0.02 (gray), ksmiR605¼ 0 and ksmiR34a¼
0.02 (dotted), ksmiR605 ¼ 0.02 and ksmiR34a ¼ 0 (dashed), and ksmiR605 ¼ 0
and ksmiR34a ¼ 0 (black). (C) Percentage of apoptotic cells from our simu-
lations (left) and from the experimental data (right).
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miR-605 accelerates the accumulation of p53DINP1, which
makes it possible for some cells to commit apoptosis at
moderate levels of DNA damage. Without enough miR-
605, the DNA damage might be fixed before [p53DINP1]
can reach the threshold, or it could take longer for [p53-
killer] to accumulate remarkably. On the other hand, enough
accumulation of free p53AIP1 is required to induce CytoC
release and Casp3 activation. miR-34a contributes to this
process of accumulation: without enough miR-34a, Casp3
may remain inactive even though [p53p] is driven to
high levels, or it may take longer to activate Casp3. Collec-
tively, both miR-34a and miR-605 can promote apoptosis
induction; miR-34a acts directly, while miR-605 acts indi-
rectly through enhancing p53 activation. It would be inter-
esting to experimentally justify the above conclusion.
With overexpression or knockdown of either miRNA and
their different combinations, the temporal evolution of
p53AIP1 and Casp3 levels is monitored so as to reveal
different effects of miR-605 and miR-34a on cellular
outcome. This may advance the understanding of how
miRNAs acting upstream or downstream of p53 regulate
its tumor suppressor function.DISCUSSION
p53 can regulate gene transcription as well as processing
and maturation of target miRNAs, and the list of p53-
targeted miRNAs grows increasingly longer (11). Several
p53-targeted miRNAs can modulate p53 activity markedly.
miR-605 is the first miRNA identified as upregulating p53
by repressing the translation of mdm2 mRNA (9). Very
recently, it was reported that miR-143 and miR-145,Biophysical Journal 106(8) 1792–1800induced by p53, also enhance p53 activation by suppressing
the translation of mdm2 mRNA (16). On the other hand,
p53-induced miR-16 promotes apoptosis by suppressing
the expression of bcl-2 (45), in a way similar to that
observed for miR-34a. For simplicity, here we chose only
miR-605 and miR-34a as two representatives of p53-tar-
geted miRNAs, which function upstream and downstream,
respectively, of p53. It would be intriguing to extend this
model to test whether the main conclusions drawn here
hold true when more proapoptotic miRNAs are added to
the p53 network.
It is noteworthy that miR-34a also enhances p53 acetyla-
tion by inhibiting the SIRT1 deacetylase posttranscription-
ally in HCT116 cells (46). However, miR-34a acts only
downstream of p53 in MCF-7 cells, where knockdown of
miR-34a does not alter the transcriptional activity of p53
(9). Thus, the function of miR-34a in the p53 network
may be specific to cell type. Here, we aimed to model non-
transformed MCF-10A cells in which the action mode of
miR-34a is similar to that seen in MCF-7 cells. In our
work, miR-605 accelerates the full activation of p53 by sup-
pressing Mdm2, while miR-34a facilitates p53-dependent
apoptosis by repressing Bcl-2. Together, miR-605 and
miR-34a can enhance the tumor suppressor function of
p53 in various ways.
Our simulation results indicate that both miR-605 and
PTEN can elevate p53 levels by downregulating nuclear
Mdm2. miR-605 represses the translation of mdm2
mRNA, while PTEN inhibits entry of Mdm2 into the nu-
cleus. They can complement each other in the upregulation
of p53 to evoke apoptosis. This may have important impli-
cations for cancer therapy. In PTEN-deficient cell lines such
as MCF-7 cells, for example, enhancing the expression of
miR-605 would contribute to full activation of p53 after
severe DNA damage. Alternatively, PTEN is required for
p53-dependent apoptosis in miR-605-deficient cell lines
such as A549 cells (9).
Our model predicts that both miR-605 and miR-34a affect
whether a cell commits to apoptosis and the timing of
apoptosis initiation. In the model, p53DINP1 should accu-
mulate enough to induce the conversion from p53-arrester
to p53-killer, and the amount of free p53AIP1 should be
high enough to activate CytoC release and Casp3 activation.
miR-605 and miR-34a contribute separately to these two
processes. Such a dual control mechanism for apoptosis in-
duction adds another level of complexity to regulation of
cellular output. Moreover, miR-605 can promote the expres-
sion of p53AIP1 to increase the total amount of p53AIP1 via
p53, which also facilitates apoptosis induction. Therefore,
miR-605 and miR-34a together endow the network with a
fail-safe mechanism for apoptosis induction.
The finding that miR-605 and miR-34a have such a
marked effect on the cell-fate decision and timing of
apoptosis is unexpected, given that they only modulate
translation of mRNAs. As seen in Fig. 3, whereas the
miR-605 and miR-34a Promote Apoptosis 1799amplitude of p53 oscillation changes slightly due to miR-
605 regulation, the activation of Casp3 can be advanced
remarkably. In a similar way, miR-34a contributes markedly
to apoptosis induction (Fig. 7 D). The coordination between
miR-605 and miR-34a also plays a key role in cell-fate con-
trol (Fig. 8). Obviously, without constructing an integrated
network model of the p53 pathway and a detailed analysis
of network dynamics, it was not possible to reveal here
the remarkable contribution of miR-605 and miR-34a to
p53-dependent apoptosis, even though we know their
connection with p53. This work suggests that the influence
of miRNAs on cellular signaling may be amplified via feed-
back and feed-forward loops, and it sheds light on the action
modes of miRNAs.
It should be noted thatmiR-605 andmiR-34a affect the cell
fate and timing of apoptosis largely because they are impor-
tant nodes of the p53 pathway and their effect on gene expres-
sion is amplified. miR-605 can upregulate p53, modulating
the conversion of p53-arrester to p53-killer, while miR-34a
affects the level of free p53AIP1, therebymediating initiation
of the caspase cascade. In our model, the kinetics of miRNA
induction are determined by p53 and do not play a critical
role in cellular outcome. Nevertheless, it is worthwhile to
systematically explore what roles the dynamics of miRNA
expression may have in a larger p53 network that includes
more miRNA species. Moreover, we previously showed
that the action mode of p53 (pulsing or switching) in the sec-
ond phase also markedly modulates the timing of apoptosis
(14). It would be interesting to compare the contribution of
these different mechanisms to cell-fate control.CONCLUSION
In this study, we developed a four-module network model to
probe the roles of two p53-targeted miRNAs, miR-605 and
miR-34a, in the modulation of p53 dynamics and DDR.
Whereas single miRNAs may have a minor effect on protein
levels, their combined effects may be amplified via various
mechanisms. Our results indicate that miR-605 can elevate
p53 levels and promote its full activation, while miR-34a
directly promotes apoptosis by inhibiting the antiapoptotic
factors. Given the protein-miRNA interactions in the p53
network, the previously proposed mechanism for cell-fate
decision by p53 pulses still holds true. With the proapoptotic
miRNAs joining the p53 network, apoptosis can be acceler-
ated to remove irreparably damaged cells promptly. There-
fore, taking into account the role of miRNAs in p53
signaling may provide new clues to p53-dependent cancer
treatments.SUPPORTING MATERIAL
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